The vast majority of human lymphoid neoplasms examined to date have been associated with a proliferation of bone marrow-dependent (B) lymphocytes. In an effort to delineate human tumors of T-cell (thymusdependent) lineage, use was made of the peripheral blood leukocytes of sixteen subjects with various forms of mycosis fungoides. The abnormal cells in the circulation of these patients are morphologically identical to those that infiltrate their nodes and skin. On electron microscopy, such neoplastic lymphocytes (S6zary cells) had "cerebriform" nuclei and an abundance of cytoplasmic fibrils not described heretofore. S6zary cells were nonadherent and nonphagocytic and usually responded to stimulation with phytohemagglutinin, refuting earlier suggestions that the cells represent monocytes or histiocytes. In contrast to chronic lymphocytic leukemia lymphocytes, the Szary cells lacked surface immunoglobulin and receptors for complement. Ultrastructural analysis identified S6zary cells in the center of directly formed rosettes (E-rosettes) characterizing the behavior of T lymphocytes in this test.
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Though some S6zary cells lacked both T and B cell-surface properties, in general, these observations support the view that the S6zary cell is a neoplastic variant of a thymusderived lymphocyte.
It is curious, that in man, in contrast to most rodents, the vast majority of chronic lymphocytic leukemias studied to date, have been associated with an increased level of circulating bone marrow-derived (B) lymphocytes (1) (2) (3) (4) (5) (6) (7) . Such cells carry immunoglobulins on their surface (8, 9) , possess membrane receptors for immunoglobulin (10, 11) and complement (12) , and respond poorly to phytohemagglutinin (PHA) in vitro (13) (14) (15) . Though it is conceivable that plasma cells and B-lymphocytes are more susceptible to mutagenic change because of their physiologic responsiveness to antigenic stimuli, it was to be anticipated that human neoplasms of thymusderived lymphocyte (T-cell) origin would also be found.
Indeed, the Sezary syndrome, a variant of mycosis fungoides in which peculiarly shaped cells infiltrate the skin, nodes, as well as circulating blood, confirmed this prediction. Preliminary studies showed that Sezary cells lacked B-cell surface markers and that they had properties of T-lymphocytes (16, 17) . The present report concerns a more extensive analysis of the cells obtained from eight patients with the diagnosis of S6zary syndrome and eight patients with the diagnosis of mycosis fungoides. In addition to the convoluted nucleus, electron microscopic studies showed that most S6zary cells contain a network of cytoplasmic fibrils not reported heretofore. To minimize the possibility that such cells are monocytes or histiocytes, we demonstrated that S6zary cells are neither adhesive nor phagocytic. The cells of most patients responded to PHA stimulation in vitro, all cells lacked B-cell surface markers, and the majority of Sezary cells, but not all, formed direct rosettes with sheep erythrocytes, suggesting that they represent T-lymphocytes.
MATERIALS AND METHODS
Patients. The diagnosis of mycosis fungoides was established by skin biopsy in all subjects. Sezary syndrome was the eponym used when the patient had generalized erythroderma, lymphadenopathy, and S6zary cells recognized on routine blood smears (18) . Skin lesions had been present from 3 months to 30 years. Except in one instance, systemic therapy had been discontinued for at least 1 month before the studies. Cell Preparation. Fifty to 100 ml of heparinized venous blood were centrifuged at 200 X g for 5 min. The mononuclear cell fraction was prepared from the plasma and buffy coat by centrifugation on a Ficoll-Hypaque mixture (Pharmacia, Uppsala, Sweden and Winthrop Laboratories, N.Y., respectively) essentially as described by Boyum (19) . Aliquots of this preparation were washed twice in Hank's solution and used for phagocytosis and electron microscopy. For the remainder of the studies, the mononuclear cell suspensions were purified further by magnetic removal of monocytes after incubation of the cells with iron filings, as described (20) ; This will be referred to as the purified lymphocyte fraction.
Phagocytosis. Before and after removal of monocytes, 5 X 108 washed cells were resuspended in 3 ml of Hank's solution containing 20% autologous plasma and 30 ,l of latex particles (Dow Chemical Co., Midland, Mich.) 0.3 ,um in diameter. The suspensions were incubated on a rotating tumbler for 20 min at 370 before fixation for electron microscopy.
Fluorescence Microscopy. Supravital immunofluorescence studies were carried out on purified lymphocytes, that had been washed three times, by utilizing polyvalent fluoresceinconjugated rabbit antiserum to human immunoglobulin essentially as described (21) .
Complement Receptor (B) Lymphocytes (EAC-Rosettes). The percentage of lymphocytes with complement receptors was quantitated essentially as by Bianco et al. (22) . Trypsinized sheep erythrocytes (E) coated with rabbit antisheep hemolysin (GIBCO, Grand Island, N.Y.) and CF1 mouse serum as a source of complement were prepared by mixing equal volumes of a 2-mg/ml of solution of trypsin (Calbiochem., LaJolla, Calif.) with 5% erythrocytes in RPMI 1640. After incubation for 1 hr at 370, an equimolar concentration of soybean trypsin inhibitor (Calbiochem., LaJolla, Calif.) was added and the cells were washed three times.
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Abbreviations: B-and T-lymphocyte, bone marrow-and thymusderived lymphocyte, respectively; PHA, phytohemagglutinin.
FIG. 1 (a and b)
. Low-power survey electron photomicrographs of purified lymphocytes from the blood of patients M.P. and P.P., respectively. Typical Sezary cells showing "cerebriform" nuclei are readily apparent, but the fibrillar structures are not resolved at this magnification. Magnification X2200. England Nuclear Corp., Boston, Mass.) in 0.1 ml of RPMI 1640 was added to each tube. The cells were processed, counted as described (24), and/or smeared and stained to assess the percentage of transformed cells.
Sheep Erythrocyte Receptor (T) Lymphocytes (E-Rosettes
Electron Microscopy. The following specimens were fixed at room temperature or at 40 in 3% phosphate-buffered glutaraldehyde overnight: (1) unwashed buffy coat cells; (2) mononuclear cells from Ficoll-Hypaque gradients before and after incubation with latex particles; (3) purified lymphocytes; (4) E-rosettes; and (5) PHA-stimulated cells. Post-fixation with 2% osmium tetroxide and embedding in Epon 812 were carried out as described (21) (25) and lead citrate (26) and viewed with a Siemens Elmiskop I electron microscope.
RESULTS
The patients with Sezary syndrome had more than 40% ultrastructurally abnormal cells among purified lymphocyte fractions. The incidence of Sezary cells in the blood of patients with mycosis fungoides varied from 0 to 30%,0. The ultrastructure of S6zary cells (Fig. la and b) has been described by others (27, 28) , who have stressed the convoluted nucleus and high glycogen content. However, it had not been noted heretofore that at high resolution the cytoplasm of most of the cells is seen to be replete with fibril$ that measure about 75 A in diameter and are of indeterminate length (Figs. 2 and 3) . The structures may be straight, curved, or undulating and, at times, resemble those described in "monocytoid" cells found in amyloid-laden lymph nodes (29) . None of the Sezary cells phagocytosed latex particles, which were readily ingested by monocytes present in the same specimen (Fig. 4) . This observation contradicts the view that the Sezary cell is a type of histiocyte or monocyte, as suggested in the past (18) . In contrast to the cells that circulate in CLL, Sezary cells carried no surface immunoglobulin or receptors for complement. Moreover, B-cells were present in low amounts (<4%) or absent from the blood of all patients (normal range 5-10%). Normal or high levels of T-lymphocytes, as measured by E-rosettes, were present in each instance. Although, on light microscopy, the leukocyte in the center of a tight rosette is not easily identifiable, electron microscopy clearly established the presence of S6zary cells in most, though not all, E-rosettes (Figs. 5 and 6 ). No S6zary cells were identified within EACrosettes. In general, the percentage of T-lymphocytes was greater than the number of S6zary cells in the same specimen, but not all Sezary cells were able to form E-rosettes (Fig. 7) .
Of 11 specimens cultured with PHA, eight showed an excellent response, two had a poor response, and one failed to respond. In one subject, treated with chemotherapy, the percentage of Sezary cells decreased from 70% to 2%, but the number of B-cells remained low and there was no longer any response to PHA.
DISCUSSION
The observations reported here support the view that the socalled S6zary cell is an abnormal variant of a T-lymphocyte. The cell lacks surface immunoglobulin as well as receptors for immunoglobulin and complement; it is nonadherent and nonphagocytic. By current criteria, these findings speak against the possibility that the cell represents a "reticulo-histiocyte," a monocyte, or B-lymphocyte. It is puzzling why, despite normal levels of bone-marrow plasma cells and serum immunoglobulin, all patients had extremely low numbers of circulating B-lymphocytes or none at all. Whether this represents only a relative deficiency or whether B-cells were replaced by neoplastic T-lymphocytes in lymphoid organs is not certain.
The (20) . (3) It has been claimed that "most, but not all Sezary cells" can be killed with antiserum cytotoxic for T-cells (30) . If one accepts the premise that the Sezary cell is a T-lymphocyte, the following features distinguish it from a normal T-cell: (a) variability in cell size, already commented on by others (31, 32) , (b) the highly convoluted nucleus (Figs. 1-7) , (c) a large amount of glycogen (28, 33) , and (d) a prominent network of cytoplasmic fibrils (Figs. 2 and 3) . The fibrils have not been commented on by others, but perusal of publications on the Sezary syndrome showed fibrillar structures in some illustrations (Fig. 7 in ref.  28 and Fig. 8 in ref. 34) . The significance of such fibrils has eluded definition for some time. They have been referred to as tonofibrils and stress fibrils, and were found by one of us in large numbers in the reticuloendothelial and other "monocytoid" cells in the lymph nodes of two patients with amyloidosis (29) . Moreover, they appear to occur in other neoplastic cells (35, 36) , in rabbit peritoneal macrophages (37) , as well as in occasional human thoracic duct lymphocytes (38) . Although contact between fibrils and the nuclear membrane was not seen, the abundance of such fibrils in Sezary cells raises the question of their relationship to the deformity of the nucleus.
The malignancy of the Sezary cell has been clearly established by the finding of abnormal karyotypes in certain patients (32, 39) . Though cytogenetic studies on our patients have not yet been extensivet, the small S6zary cells of C.S. were aneuploid, whereas the large cells of M.P., had a normal karyotype. Thus it remains to be seen whether classification into a large-cell and a small-cell variant, as pointed out by Lutzner (32) , will prove to be useful. We have observed small cells with an average diameter of 10,m as well as large cells with a diameter of about 20,um in one of our specimens. The clinical argument whether or not the Sezary syndrome should be considered a separate disease entity from mycosis fungoides is not relevant to this discussion. It seems more cogent to ask whether similar cells, when found in other lymphoid tumors, particularly those involving the skin (40) , also consist of T-lymphocytes. To date Sezary-like cells have been described in the biopsy specimen of a patient with cutaneous reticulum cell sarcoma and in two subjects with the benign condition, lichen planus (41) . Tests for cell-surface markers had not been carried out in these cases. We hope that the recent introduction of a technique that may permit localization of T-cells in normal lymphoid organs (42) , may be of help in the detection of other lymphoid neoplasms of possible T-cell origin.
